Skip to main content
Santhera Pharmaceuticals Holding AG (SWX: SANN)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
14.46
+0.64 (4.63%)
Jan 3, 2025, 5:31 PM CET

SWX: SANN Revenue

Santhera Pharmaceuticals Holding AG had revenue of 14.11M CHF in the half year ending June 30, 2024, with 125.82% growth. This brings the company's revenue in the last twelve months to 113.59M, up 2,100.48% year-over-year. In the year 2023, Santhera Pharmaceuticals Holding AG had annual revenue of 103.41M with 1,283.84% growth.

Revenue (ttm)
113.59M
Revenue Growth
+2,100.48%
P/S Ratio
1.36
Revenue / Employee
2.52M
Employees
45
Market Cap
175.05M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023103.41M95.94M1,283.84%
Dec 31, 20227.47M9.07M-568.53%
Dec 31, 2021-1.60M-16.60M-110.63%
Dec 31, 202015.01M-60.37M-80.09%
Dec 31, 201975.38M43.72M138.10%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Roche Holding AG 60.58B
Novartis AG 42.18B
Lonza Group AG 6.70B
Alcon 8.25B
Galderma Group AG 3.88B
Straumann Holding AG 2.54B
Sonova Holding AG 3.71B
Sandoz Group AG 9.09B
Revenue Rankings

Santhera Pharmaceuticals Holding AG News

More News